Hirsh Nanda

Johnson & Johnson (United States)

Papers

1

Total Citations

24

H-Index

1

About

Hirsh Nanda is a leading innovator in the field of biopharmaceutical characterization, with a primary focus on advancing high-throughput mass spectrometry (MS) for the analysis of biotherapeutics. His most notable contribution is the pioneering development of the "Lab of the Future"—a fully automated, integrated system that revolutionizes the characterization of therapeutic proteins. This system, detailed in his highly cited 2023 paper (24 citations), seamlessly combines liquid handling robotics, microplate automation, and integrated LC-MS with advanced data analysis software. By automating complex, multi-step MS workflows, Nanda’s work dramatically accelerates the speed, reproducibility, and throughput of biotherapeutic analysis, addressing a critical bottleneck in drug development. His contributions are pivotal for enabling rapid, high-quality decision-making in the biotech industry, directly impacting the efficiency of candidate screening and quality control. Through this landmark achievement, Nanda has positioned himself at the forefront of laboratory automation and analytical biotechnology, providing a tangible blueprint for the next generation of intelligent, data-driven biopharma labs.

Research Focus

Key Achievements

1
H-Index
1
Papers
24
Total Citations
24
Avg Citations/Paper
🏆 Most Cited Paper
“Lab of the Future”─Today: Fully Automated System for High-Throughput Mass Spectrometry Analysis of Biotherapeutics
24 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 13
🏛 Institutions: Johnson & Johnson (United States)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago